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dewetting forces cannot break crosslinked PLGA coating, but theetter  to  the  Editor
ith reference to article: “Impact of the ﬁrst-
eneration drug-eluting stent implantation on
eriprocedural myocardial injury in patients
ith stable angina pectoris”. Dewetting problem
Biodegradable polymers are used as an effective matrix for drug-
luting coating on vascular stents [1]. Such polymers degrade in
he human organism with a hydrolysis reaction that releases drugs
nd products of polymer degradation. The released drugs prevent
n inﬂammatory reaction and thrombosis, suppress neointimal
yperplasia, and reduce the risk of restenosis. The organism metab-
lizes the released products of polymer degradation safely. Due
o these advantages, drug-eluting stents have found a wide appli-
ation in vascular surgery in comparison with bare metal stents.
owever, the question of whether drug-eluting stents show sig-
iﬁcant improvement in comparison with uncoated bare stents
emains and is discussed (for example, Okada et al. reported that
2]: “. . .use of [drug-eluting stents] has not improved mortality in
atients with [angina pectoris] in spite of their notable suppressive
ffect for neointimal hyperplasia compared to that of [bare metal
tents]”).
One reason for the contradiction could be due to a particularity
f the biodegradation process in polymer coating on metal sur-
ace. A polymer coating has signiﬁcantly different surface energy
han a metal surface on the stent. Therefore, these two  substances
ill minimize the contact area. The reason is a dewetting effect of
olymer coating on all metal surfaces including metal stents [3,4].
We  investigated vascular drug-eluting stents with poly(lactic-
o-glycolic acid) (PLGA) coating (polymer base for drug) as
ell as a model PLGA coating on silicon wafer (http://arxiv.org/
df/1101.0659v1). The initial PLGA coating on silicon wafer is
mooth and stable. After exposure in water solution the PLGA
oating swells with water, becomes soft and mobile. As result of
obility, the PLGA coating becomes ruptured, the ruptured parts
ove and collect as separate drops with naked metal areas between
hem (Fig. 1A). With time the drop sizes decrease due to biodegra-
ation of PLGA. The dewetting process takes about 1–3 days and
he biodegradation process takes 2–3 weeks. Therefore, the coat-
ng stands on stents as separate drops during most of the time of
iodegradation.
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difference between surface energy of coating and metal, surface
tension of polymer, geometry of the surface, density, and viscosity
of the coating [3,4]. The distribution of the drops shows that the
dewetting occurs by spinodal mechanism. That means the coating
is unstable on the metal due to a difference in surface energy of the
metal and PLGA coating.
The separation of PLGA coating to small drops, a peeling off of
the drops from the stent surface, and a move to periphery vessels,
where the PLGA drops can block blood ﬂow, is strongly possi-
ble. The metal surface of the stent comes into direct contact with
blood after a short time in water solution. These changes could
cause periprocedural myocardial injury (PMI) as it was suggested
by Okada et al. [2]: “we  hypothesized that [drug-eluting stent]
implantation may  be associated with a higher incidence of PMI and
affect the clinical outcome after [percutaneous coronary interven-
tion]”.
The dewetting of PLGA coating on metal substrates can
be stopped. We  used ion beam implantation to modify the
PLGA coating. During modiﬁcation, high energy ions cause dam-
age to a number of chemical bonds in PLGA and replace
atoms from polymer macromolecules in the trace of ions.
Replaced atoms join together to each other and join to resid-
ual macromolecules so that the modiﬁed coating becomes highly
crosslinked. The ﬁlm becomes immovable. Dewetting stops
(Fig. 1B).
The ion beam modiﬁed PLGA coating remains smooth and stable
during the complete time of biodegradation. The coating is fully
crosslinked and does not dewet. The degradation process occurs
uniformly.
The same effect of dewetting is observed on metal stents. The
initial coating before biodegradation is smooth. After biodegrada-
tion the untreated stent has a ruptured coating and part of the stent
surface is naked up to metal (Fig. 1C). The ion beam treated coat-
ing remains stable on stents during biodegradation (Fig. 1D). Thedrug is released freely.
The study was supported by Boston Scientiﬁc, Natick, MA,
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vier Ltd. All rights reserved.
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Fig. 1. Microphotographs of silicon wafer ((A) and (B), size of photos is 1.2 mm × 0.95 mm)  and stents ((C) and (D), size of photos is 0.24 mm × 0.19 mm)  with poly(lactic-co-
g  biode
( degra
r
R
[
[
[
[lycolic  acid) coating. (A) The untreated coating is dewetted to separate drops after
C)  the untreated coating on stent is dewetted to non-regular structures after bio
emains  continuous.
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